vs
Side-by-side financial comparison of Golden Matrix Group, Inc. (GMGI) and Vericel Corp (VCEL). Click either name above to swap in a different company.
Vericel Corp is the larger business by last-quarter revenue ($92.9M vs $49.6M, roughly 1.9× Golden Matrix Group, Inc.). Vericel Corp runs the higher net margin — 25.0% vs -179.0%, a 204.0% gap on every dollar of revenue. On growth, Vericel Corp posted the faster year-over-year revenue change (23.3% vs -15.8%). Vericel Corp produced more free cash flow last quarter ($12.8M vs $6.4M). Over the past eight quarters, Golden Matrix Group, Inc.'s revenue compounded faster (104.6% CAGR vs 34.6%).
Golden Matrix Group Inc. is a global gaming tech firm that develops and licenses proprietary online gaming platforms, social casino products and interactive solutions. It serves B2B gaming operator clients across North America, Europe and Asia-Pacific, plus runs direct-to-consumer casual gaming properties.
Vericel Corporation is a publicly traded American biopharmaceutical company which was known prior to October 2014 as Aastrom Bio. Aastrom Bio was formed in 1989 in Ann Arbor, Michigan.
GMGI vs VCEL — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $49.6M | $92.9M |
| Net Profit | $-88.7M | $23.2M |
| Gross Margin | 57.5% | 78.7% |
| Operating Margin | -188.3% | 24.1% |
| Net Margin | -179.0% | 25.0% |
| Revenue YoY | -15.8% | 23.3% |
| Net Profit YoY | -4880.1% | 17.3% |
| EPS (diluted) | $-7.73 | $0.46 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $49.6M | $92.9M | ||
| Q3 25 | $47.3M | $67.5M | ||
| Q2 25 | $43.2M | $63.2M | ||
| Q1 25 | $42.7M | $52.6M | ||
| Q4 24 | $58.9M | $75.4M | ||
| Q3 24 | $41.0M | $57.9M | ||
| Q2 24 | $39.4M | $52.7M | ||
| Q1 24 | $11.8M | $51.3M |
| Q4 25 | $-88.7M | $23.2M | ||
| Q3 25 | $566.0K | $5.1M | ||
| Q2 25 | $-3.6M | $-553.0K | ||
| Q1 25 | $-231.6K | $-11.2M | ||
| Q4 24 | $1.9M | $19.8M | ||
| Q3 24 | $-3.4M | $-901.0K | ||
| Q2 24 | $64.9K | $-4.7M | ||
| Q1 24 | $74.5K | $-3.9M |
| Q4 25 | 57.5% | 78.7% | ||
| Q3 25 | 55.8% | 73.5% | ||
| Q2 25 | 56.4% | 73.7% | ||
| Q1 25 | 56.6% | 69.0% | ||
| Q4 24 | 69.8% | 77.6% | ||
| Q3 24 | 54.7% | 71.9% | ||
| Q2 24 | 55.0% | 69.5% | ||
| Q1 24 | 28.5% | 68.9% |
| Q4 25 | -188.3% | 24.1% | ||
| Q3 25 | -0.8% | 5.1% | ||
| Q2 25 | -5.3% | -3.2% | ||
| Q1 25 | -0.2% | -24.3% | ||
| Q4 24 | 5.6% | 24.5% | ||
| Q3 24 | -2.4% | -4.3% | ||
| Q2 24 | 0.3% | -11.5% | ||
| Q1 24 | 2.4% | -10.7% |
| Q4 25 | -179.0% | 25.0% | ||
| Q3 25 | 1.2% | 7.5% | ||
| Q2 25 | -8.3% | -0.9% | ||
| Q1 25 | -0.5% | -21.4% | ||
| Q4 24 | 3.2% | 26.3% | ||
| Q3 24 | -8.3% | -1.6% | ||
| Q2 24 | 0.2% | -8.9% | ||
| Q1 24 | 0.6% | -7.5% |
| Q4 25 | $-7.73 | $0.46 | ||
| Q3 25 | $0.00 | $0.10 | ||
| Q2 25 | $-0.03 | $-0.01 | ||
| Q1 25 | $0.00 | $-0.23 | ||
| Q4 24 | $-0.13 | $0.40 | ||
| Q3 24 | $-0.03 | $-0.02 | ||
| Q2 24 | $0.00 | $-0.10 | ||
| Q1 24 | $0.00 | $-0.08 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $137.5M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $46.5M | $354.6M |
| Total Assets | $118.1M | $488.0M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $137.5M | ||
| Q3 25 | — | $135.4M | ||
| Q2 25 | — | $116.9M | ||
| Q1 25 | — | $112.9M | ||
| Q4 24 | — | $116.2M | ||
| Q3 24 | — | $101.7M | ||
| Q2 24 | — | $102.5M | ||
| Q1 24 | — | $110.6M |
| Q4 25 | $46.5M | $354.6M | ||
| Q3 25 | $123.5M | $321.9M | ||
| Q2 25 | $121.3M | $306.8M | ||
| Q1 25 | $108.5M | $295.5M | ||
| Q4 24 | $105.1M | $292.0M | ||
| Q3 24 | $94.3M | $257.5M | ||
| Q2 24 | $90.4M | $243.0M | ||
| Q1 24 | $32.1M | $233.9M |
| Q4 25 | $118.1M | $488.0M | ||
| Q3 25 | $209.8M | $453.3M | ||
| Q2 25 | $210.3M | $435.6M | ||
| Q1 25 | $214.0M | $424.6M | ||
| Q4 24 | $213.7M | $432.7M | ||
| Q3 24 | $213.5M | $390.4M | ||
| Q2 24 | $191.5M | $376.8M | ||
| Q1 24 | $37.1M | $356.7M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $8.2M | $15.0M |
| Free Cash FlowOCF − Capex | $6.4M | $12.8M |
| FCF MarginFCF / Revenue | 13.0% | 13.8% |
| Capex IntensityCapex / Revenue | 3.6% | 2.4% |
| Cash ConversionOCF / Net Profit | — | 0.65× |
| TTM Free Cash FlowTrailing 4 quarters | $19.2M | $24.7M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $8.2M | $15.0M | ||
| Q3 25 | $7.0M | $22.1M | ||
| Q2 25 | $2.4M | $8.2M | ||
| Q1 25 | $7.7M | $6.6M | ||
| Q4 24 | — | $22.2M | ||
| Q3 24 | $4.8M | $10.2M | ||
| Q2 24 | — | $18.5M | ||
| Q1 24 | $8.2K | $7.2M |
| Q4 25 | $6.4M | $12.8M | ||
| Q3 25 | $6.2M | $19.5M | ||
| Q2 25 | $-89.4K | $81.0K | ||
| Q1 25 | $6.6M | $-7.6M | ||
| Q4 24 | — | $8.5M | ||
| Q3 24 | $2.3M | $-9.2M | ||
| Q2 24 | — | $1.8M | ||
| Q1 24 | $6.7K | $-6.8M |
| Q4 25 | 13.0% | 13.8% | ||
| Q3 25 | 13.1% | 28.8% | ||
| Q2 25 | -0.2% | 0.1% | ||
| Q1 25 | 15.5% | -14.5% | ||
| Q4 24 | — | 11.2% | ||
| Q3 24 | 5.6% | -15.9% | ||
| Q2 24 | — | 3.4% | ||
| Q1 24 | 0.1% | -13.3% |
| Q4 25 | 3.6% | 2.4% | ||
| Q3 25 | 1.8% | 3.9% | ||
| Q2 25 | 5.7% | 12.9% | ||
| Q1 25 | 2.6% | 27.0% | ||
| Q4 24 | — | 18.3% | ||
| Q3 24 | 6.0% | 33.5% | ||
| Q2 24 | — | 31.8% | ||
| Q1 24 | 0.0% | 27.3% |
| Q4 25 | — | 0.65× | ||
| Q3 25 | 12.42× | 4.35× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 1.12× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 0.11× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
GMGI
| R Kings And CFAC | $43.8M | 88% |
| Other | $5.8M | 12% |
VCEL
| MACI Implants And Kits | $84.1M | 90% |
| Other | $8.8M | 10% |
